Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Clinical trial NCT01014208 · COMPLETED

Trial details

NCT number: NCT01014208
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Large-Cell, Diffuse

Start date: 2010-03-01
Primary completion: 2014-02-01
Enrollment: 447

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.